Poland· PL-100382582

Tobramycyna SUN

A tobramycin product containing tobramycinum, registered in Poland by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC J01GB01

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tobramycinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tobramycin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01GB01 (tobramycin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search tobramycin products by name

Tobramycin · ATC J01GB01

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tobramycin costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Tobramycin · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$98.67

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Tobramycinum
Manufacturer: Sun Pharmaceutical Industries Europe B.V.
Country: Poland (PL)
ATC code: J01GB01
ATC class: Tobramycin
Defined daily dose: 0.3 g, Inhal
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 3

gtin
05909991321444
gtin
05909991321451
gtin
05909991321468

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

191 interactions on record for tobramycin.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tobramycin against other medicines How interaction checks work

Tobramycin · interactions on record

191 records

29 severe
62 moderate
2 minor
98 info

Most severe, free to view

Magnesium sulfateA06AD04severe
MannitolA06AD16severe
Polymyxin BA07AA05severe
Magnesium sulfateA12CC02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tobramycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tobramycin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Bramitob, Tobi
Belgium · Obracin, Tobi
Bulgaria · Tобрекс, Тобрамизил
Cyprus · Bramitob, Ikobel
Czechia · Bramitob, Tobramycin Vioser
Germany · Bramitob, Gernebcin
Denmark · Nebcina, Tobi
Estonia · Tobramycin Via Pharma, Tobrex
Spain · Bramitob, Tobrabact
Finland · Tobi
France · Nebcine, Tobi
United Kingdom (Northern Ireland) · Bramitob, Munuza
Greece · Bramitob, Eyetobrin
Croatia · Bramitob, Tobrex
Hungary · Bramitob, Brulamycin
Ireland · Bramitob, Tobi
Iceland · Tobi Podhaler, Vantobra
Italy · Bramicil, Bramitob
Liechtenstein · Tobi Podhaler, Vantobra
Lithuania · Bramitob, Tobramycin Via Pharma
Luxembourg · Obracin, Tobi
Latvia · Bramitob, Tobramycin Via Pharma
Malta · Tobi, Tobrex
Netherlands · Bramitob, Obracin
Norway · Bramitob, Nebcina
Portugal · Bramitob, Tobi
Romania · Tobi, Tobramicină Sun
Sweden · Bramitob, Nebcina
Slovenia · Tobrex
Slovakia · Bramitob, Tobrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/20c6559c-cf43-4672-81b5-d0f9a6d98028
GET /v1/drugs/20c6559c-cf43-4672-81b5-d0f9a6d98028?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do nebulizacji",
  "source": "urpl",
  "strength": "300 mg/5 ml",
  "packaging": "05909991321444 ¦ Rp ¦ 121058\n56 amp. 5 ml\n05909991321451 ¦ Rp ¦ 121059\n112 amp. 5 ml\n05909991321468 ¦ Rp ¦ 121060\n168 amp. 5 ml",
  "substance": "Tobramycinum 300 mg/ampułkę",
  "common_name": "Tobramycinum",
  "pl_product_id": "100382582",
  "pozwolenie_nr": "23837",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about tobramycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console